Drug name - Savaysa
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7365205 | DAIICHI SANKYO INC | Diamine derivatives |
Apr, 2027
(4 years from now) | |
| CN100545160C | DAIICHI SANKYO INC | Diamine Derivatives |
Oct, 2012
(9 years ago) | |
| CN1894238A | DAIICHI SANKYO INC | Diamine Derivatives |
Oct, 2012
(9 years ago) | |
| CN1826333B | DAIICHI SANKYO INC | Diamine Derivatives |
Mar, 2022
(6 months ago) | |
| CN1826333A | DAIICHI SANKYO INC | Diamine Derivatives |
Mar, 2022
(6 months ago) | |
| EP1415992A4 | DAIICHI SANKYO INC | Diamine Derivatives |
Aug, 2022
(a month ago) | |
| EP1415992A1 | DAIICHI SANKYO INC | Diamine Derivatives |
Aug, 2022
(a month ago) | |
| EP1415992B1 | DAIICHI SANKYO INC | Diamine Derivatives |
Aug, 2022
(a month ago) | |
| EP1405852B9 | DAIICHI SANKYO INC | Diamine Derivatives |
Jun, 2027
(4 years from now) | |
| EP1405852B1 | DAIICHI SANKYO INC | Diamine Derivatives |
Jun, 2027
(4 years from now) | |
| EP1405852A4 | DAIICHI SANKYO INC | Diamine Derivatives |
Jun, 2027
(4 years from now) | |
| EP1405852A1 | DAIICHI SANKYO INC | Diamine Derivatives |
Jun, 2027
(4 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9149532 | DAIICHI SANKYO INC | Pharmaceutical composition |
Mar, 2028
(5 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 15MG BASE | TABLET;ORAL | Prescription |
| EQ 30MG BASE | TABLET;ORAL | Prescription |
| EQ 60MG BASE | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.